Pages that link to "Item:Q2103601"
From MaRDI portal
The following pages link to Mathematical modeling for the combination treatment of IFN-\(\gamma\) and anti-PD-1 in cancer immunotherapy (Q2103601):
Displaying 13 items.
- B7-H1 and a mathematical model for cytotoxic T cell and tumor cell interaction (Q417323) (← links)
- A mechanistic systems pharmacology modeling platform to investigate the effect of PD-L1 expression heterogeneity and dynamics on the efficacy of PD-1 and PD-L1 blocking antibodies in cancer (Q2029579) (← links)
- Cancer therapy with immune checkpoint inhibitor and CSF-1 blockade: a mathematical model (Q2109247) (← links)
- Mathematical modeling and analysis of CD200-CD200R in cancer treatment (Q2154530) (← links)
- A mathematical model of tumor-immune interactions with an immune checkpoint inhibitor (Q2286039) (← links)
- Mathematical modeling of cancer treatment with radiation and PD-L1 inhibitor (Q2303919) (← links)
- Antagonism and negative side-effects in combination therapy for cancer (Q2316397) (← links)
- Modeling LSD1-mediated tumor stagnation (Q2659798) (← links)
- THE EFFECT OF LENVATINIB AND PEMBROLIZUMAB ON THYROID CANCER REFRACTORY TO IODINE 131I SIMULATED BY MATHEMATICAL MODELING (Q5080062) (← links)
- Combination therapy for cancer with IL-27 and anti-PD-1: A simplified mathematical model (Q5879157) (← links)
- Dynamic analysis of a drug resistance evolution model with nonlinear immune response (Q6594614) (← links)
- Mathematical modeling of tumor immune interactions: the role of anti-FGFR and anti-PD-1 in the combination therapy (Q6597999) (← links)
- Targeting CD4+ T cell exhaustion to improve future immunotherapy strategies (Q6661649) (← links)